Symptoms
Last updated: 2024 Nov 18
Total hit(s): 24297
S.No.
1
39524183
Network-based virus dynamic simulation: Evaluating the fomite disinfection effectiveness on SARS-CoV-2 transmission in indoor environment.
Infect Dis Model
2025 Mar
- n/a -
1
2
39550100
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination.
Rheum Dis Clin North Am
2025 Feb
1
3
39550106
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients.
Rheum Dis Clin North Am
2025 Feb
1
4
39550108
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination: A Narrative Review.
Rheum Dis Clin North Am
2025 Feb
1
5
39182703
Diosmetin-7-O-beta-D-glucopyranoside from Pogostemonis Herba alleviated SARS-CoV-2-induced pneumonia by reshaping macrophage polarization and limiting viral replication.
J Ethnopharmacol
2025 Jan 10
6.8
1
6
39277919
SARS-CoV-2 detection in COVID-19 patients' sample using Wooden quoit conformation structural aptamer (WQCSA)-Based electronic bio-sensing system.
Biosens Bioelectron
2025 Jan 1
9.52
1
7
39438029
Veno-venous extracorporeal membrane oxygenation for severe COVID-19 associated acute respiratory distress syndrome: A retrospective, nationwide, Danish cohort study.
Acta Anaesthesiol Scand
2025 Jan
2.15
1
8
38195430
Hyperferritinemia as a factor associated with poor prognosis in COVID-19 patients.
Ceska Slov Farm
2024 Winter
0.36
1
9
38185645
Hyperferritinemia as a factor associated with poor prognosis in COVID-19 patients.
Ceska Slov Farm
2024 Winter
0.36
1
10
38988848
Presumed Fourth Nerve Palsy in a Healthy and Asymptomatic Child with COVID-19 Infection.
Iran J Child Neurol
2024 Summer
1
11
38556935
Symptom Exacerbations of Patients Attending a Community Mental Health Center During the COVID-19 Pandemic.
Turk Psikiyatri Derg
2024 Spring
1
12
39422261
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
13
39081126
Development and validation of a COVID-19 vaccination prediction model based on self-reporting results in Chinese older adults from September 2022 to November 2022: A nationwide cross-sectional study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
14
38752704
Comprehensive insights into COVID-19 vaccine-associated multiple evanescent white dot syndrome (MEWDS): A systematic analysis of reported cases.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
15
38407186
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
16
38512394
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
17
38372198
Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018(R) adjuvant.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
18
38206168
SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
19
38174857
Hypophysitis after COVID-19 vaccination in a patient with Rathke's cleft cyst: A case report.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
20
38787317
Regarding "Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic".
Hum Vaccin Immunother
2024 Dec 31
4.7
1
N/A
21
38658178
Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemic.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
22
38468184
Unraveling the copper-death connection: Decoding COVID-19's immune landscape through advanced bioinformatics and machine learning approaches.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
23
38445561
Parental intention on getting children COVID-19 vaccinations: Invariance evaluation across parenting roles and COVID-19-like symptoms experiences among Iranians during the pandemic period.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
24
39434214
Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
25
38709953
Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
N/A